CIK 0001285819 · Non-accelerated filer<br>Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 911663741
- Phone
- 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,114,339
- in 5 filings, $626K under 10b5-1 plans
Net −$2,114,339. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-17 | Cable Thomas J. Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-06-17 | Bumol Thomas F. Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-09-08 | HANISH ARNOLD C Director | Option exercise | +10,000 | $9.44 | $94K | 10,000 |
| 2021-09-08 | HANISH ARNOLD C Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 5,000 | ||
| 2021-07-02 | Cancelmo Peter B VP, GEN. COUNSEL & CORP. SEC. | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2021-07-02 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2021-07-02 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Grant or award · Stock Option (right to buy) | +550,000 | 550,000 | ||
| 2021-06-17 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Option exercise | +36,857 | $4.10 | $151K | 2,063,843 |
| 2021-06-17 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Sale | −36,857 | $14.90 | $549K | 2,026,986 |
| 2021-06-17 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Option exercise · Stock Option (right to buy) | −36,857 | 0 | ||
| 2021-06-15 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Option exercise | +36,856 | $4.10 | $151K | 2,063,842 |
| 2021-06-15 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Sale | −36,856 | $15.02 | $554K | 2,026,986 |
| 2021-06-15 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Option exercise · Stock Option (right to buy) | −36,856 | 36,857 | ||
| 2021-06-11 | Zumwalt Kurt Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-06-11 | Cable Thomas J. Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-06-11 | HANISH ARNOLD C Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-06-11 | Hood Leroy E. MD PhD Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-06-11 | Demopulos Peter A MD Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-06-11 | Shah Rajiv Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2021-06-11 | Bumol Thomas F. Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 |
Page 7 of 9 · 178 trades